An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing

BMC Evolutionary Biology

Volumn 10, Issue 1, 2010, Pages

  Johnson, Keven R ^a   Nicodemus Johnson, Jessie ^b   Danziger, Robert S ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYESIAN ANALYSIS; COMPARTMENTALIZATION; ENZYME ACTIVITY; EVOLUTIONARY BIOLOGY; GENE EXPRESSION; GENETIC ANALYSIS; HYDROLYSIS; MAXIMUM LIKELIHOOD ANALYSIS; PHYLOGENETICS; PROTEIN; PROTEOMICS; VERTEBRATE;

INVERTEBRATA; MAMMALIA; TELEOSTEI; TETRAPODA; VERTEBRATA;

ISOENZYME; PHOSPHODIESTERASE IV;

ALTERNATIVE RNA SPLICING; ANIMAL; ARTICLE; BAYES THEOREM; DNA SEQUENCE; EXON; GENE DUPLICATION; GENETICS; HUMAN; MOLECULAR EVOLUTION; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROMOTER REGION; PROTEIN DOMAIN; STATISTICAL MODEL;

ALTERNATIVE SPLICING; ANIMALS; BAYES THEOREM; CONSERVED SEQUENCE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; EVOLUTION, MOLECULAR; EXONS; GENE DUPLICATION; HUMANS; ISOENZYMES; LIKELIHOOD FUNCTIONS; MULTIGENE FAMILY; PHYLOGENY; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEQUENCE ANALYSIS, DNA;

EID: 77955396924     PISSN: None     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/1471-2148-10-247     Document Type: Article

References (43)

1. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. M Conti J Beavo, Annu Rev Biochem 2007 76 481 511 10.1146/annurev.biochem.76.060305.150444 17376027
2. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. YH Jeon,, et al. Cell Mol Life Sci 2005 62 11 1198 220 10.1007/s00018-005-4533-5 15798894
3. AKAP signalling complexes: focal points in space and time. W Wong JD Scott, Nat Rev Mol Cell Biol 2004 5 12 959 70 10.1038/nrm1527 15573134
4. Dynamics of signaling by PKA. SS Taylor,, et al. Biochim Biophys Acta 2005 1754 1-2 25 37 16214430
5. Epac proteins: multi-purpose cAMP targets. JL Bos, Trends Biochem Sci 2006 31 12 680 6 10.1016/j.tibs.2006.10.002 17084085
6. The fourth dimension in cellular signaling. JW Karpen TC Rich, Science 2001 293 5538 2204 5 10.1126/science.293.5538.2204 11569497
7. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. MD Houslay GS Baillie DH Maurice, Circ Res 2007 100 7 950 66 10.1161/01.RES.0000261934. 56938.38 17431197
8. Overview of PDEs and their regulation. K Omori J Kotera, Circ Res 2007 100 3 309 27 10.1161/01.RES.0000256354.95791.f1 17307970
9. Ancient gene duplication and domain shuffling in the animal cyclic nucleotide phosphodiesterase family. M Koyanagi,, et al. FEBS Lett 1998 436 3 323 8 10.1016/S0014-5793(98)01150-8 9801141
10. PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases. AC McCahill,, et al. Handb Exp Pharmacol 2008 186 125 66 full-text 18491051
11. Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter. IR Le Jeune,, et al. J Biol Chem 2002 277 39 35980 9 10.1074/jbc.M204832200 12121997
12. Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10. G Rena,, et al. Mol Pharmacol 2001 59 5 996 1011 11306681
13. Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene. DA Wallace,, et al. Mol Pharmacol 2005 67 6 1920 34 10.1124/mol.104.009423 15738310
14. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases. GS Baillie, FEBS J 2009 276 7 1790 9 10.1111/j.1742-4658.2009.06926.x 19243430
15. Tailoring cAMP-signalling responses through isoform multiplicity. MD Houslay G Milligan, Trends Biochem Sci 1997 22 6 217 24 10.1016/S0968-0004(97) 01050-5 9204709
16. cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm for understanding the unique non-redundant roles that PDE4 isoforms play in shaping compartmentalized cAMP cell signalling. MJ Lynch GS Baillie MD Houslay, Biochem Soc Trans 2007 35 Pt 5 938 41 17956250
17. Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation. Identification and function of an inhibitory domain. J Lim G Pahlke M Conti, J Biol Chem 1999 274 28 19677 85 10.1074/jbc.274.28.19677 10391907
18. Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs). W Richter M Conti, J Biol Chem 2002 277 43 40212 21 10.1074/jbc.M203585200 12177055
19. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions. MB Beard,, et al. J Biol Chem 2000 275 14 10349 58 10.1074/jbc.275.14.10349 10744723
20. Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition. I McPhee,, et al. J Biol Chem 1999 274 17 11796 810 10.1074/jbc.274.17.11796 10206997
21. Evolution by Gene Duplication. S Ohno, 1970
22. The 2R hypothesis: an update. M Kasahara, Curr Opin Immunol 2007 19 5 547 52 10.1016/j.coi.2007.07.009 17707623
23. Evolution of alternative splicing after gene duplication. Z Su,, et al. Genome Res 2006 16 2 182 9 10.1101/gr.4197006 16365379
24. Design of phosphodiesterase 4 D (PDE4D) allosteric modulators for enhancing cognition with improved safety. AB Burgin,, et al. Nat Biotechnol 28 1 63 70 10.1038/nbt.1598 20037581
25. Putting the lid on phosphodiesterase 4. MD Houslay DR Adams, Nat Biotechnol 28 1 38 40 10.1038/nbt0110-38 20062038
26. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases. GS Baillie,, et al. Br J Pharmacol 2000 131 4 811 9 10.1038/sj.bjp.0703636 11030732
27. Graphical models of residue coupling in protein families. J Thomas N Ramakrishnan C Bailey-Kellogg, IEEE/ACM Trans Comput Biol Bioinform 2008 5 2 183 97 10.1109/TCBB.2007.70225 18451428
28. Character and evolution of protein-protein interfaces. I Res O Lichtarge, Phys Biol 2005 2 2 36 43 10.1088/1478-3975/2/2/S04 16204847
29. Splice variants of the cyclic nucleotide phosphodiesterase PDE4 D are differentially expressed and regulated in rat tissue. W Richter SL Jin M Conti, Biochem J 2005 388 Pt 3 803 11 15717866
30. Profiling human phosphodiesterase genes and splice isoforms. J Bingham S Sudarsanam S Srinivasan, Biochem Biophys Res Commun 2006 350 1 25 32 10.1016/j.bbrc.2006.08.180 16987497
31. Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+. E Huston,, et al. J Cell Sci 2006 119 Pt 18 3799 810 10.1242/jcs.03106 16940352
32. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. KL Dodge,, et al. EMBO J 2001 20 8 1921 30 10.1093/emboj/20.8.1921 11296225
33. PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. JJ Carlisle Michel,, et al. Biochem J 2004 381 Pt 3 587 92 15182229
34. Phosphodiesterase 4 D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. SE Lehnart,, et al. Cell 2005 123 1 25 35 10.1016/j.cell.2005.07.030 16213210
35. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. GS Baillie,, et al. Proc Natl Acad Sci USA 2003 100 3 940 5 10.1073/pnas.262787199 12552097
36. Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. GS Baillie MD Houslay, Curr Opin Cell Biol 2005 17 2 129 34 10.1016/j.ceb.2005.01.003 15780588
37. Cloning and characterization of novel PDE4 D isoforms PDE4D6 and PDE4D7. D Wang,, et al. Cell Signal 2003 15 9 883 91 10.1016/S0898-6568(03)00042-1 12834813
38. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6). YF Cheung,, et al. J Pharmacol Exp Ther 2007 322 2 600 9 10.1124/jpet.107.122218 17519386
39. ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4 D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. SJ MacKenzie,, et al. J Biol Chem 2000 275 22 16609 17 10.1074/jbc.275.22.16609 10828059
40. Purification and characterization of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells. PI Lario,, et al. Arch Biochem Biophys 2001 394 1 54 60 10.1006/abbi.2001.2513 11566027
41. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. T Heinemeyer,, et al. Nucleic Acids Res 1999 27 1 318 22 10.1093/nar/27.1.318 9847216
42. PipMaker - a web server for aligning two genomic DNA sequences. S Schwartz,, et al. Genome Res 2000 10 4 577 86 10.1101/gr.10.4.577 10779500
43. PipTools: a computational toolkit to annotate and analyze pairwise comparisons of genomic sequences. L Elnitski,, et al. Genomics 2002 80 6 681 90 10.1006/geno.2002.7018 12504859